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Introduction 
 
Biocatalysis involves the utilization of biological substances, 
enzymes or whole-cell systems, for the synthesis of valuable organic 
molecules in processes traditionally based on the use of chemical 
synthesis [1, 2]. In recent years, the use of biocatalysis in industrial 
processes has become more common as it offers efficient tools for 
transformation of natural or synthetic materials under mild reaction 
conditions, reduced energy and raw material consumption. 
Furthermore, biocatalysis enables the synthesis of new chemicals and 
decreases the generation of waste and toxic side-products, as 
compared to the equivalent chemical catalyst [3-6]. 
One group of biocatalysts with special interest for the chemical 
industry is the oxygenases. Oxygenases are enzymes that catalyze the 
introduction of one (monooxygenases) or two (dioxygenases) oxygen 
atoms into an organic substance. They typically use molecular oxygen 
(O2) as the oxygen donor and most of them require reduction 
equivalents usually supplied from NADH or NADPH by electron 
transfer proteins [7-10]. Most oxygenases are cofactor-dependent 
enzymes requiring metal-ions (e.g., copper or iron), metal-ion 
complexes (e.g., heme, Fe-S cluster) or coenzymes (e.g., flavin, pterin, 
pyrroloquinoline quinone) [7-10].  
Oxygenases are attractive biocatalysts as they react with a vast 
variety of organic molecules and enable improved product purity by 
highly chemo-, regio- and stereo-selectivity in contrast to the poor 
selectivity of the strong oxidizing agents and the extreme reaction 
conditions of traditional organic chemical synthesis [7-9]. Various 
industrial applications based on oxygenases already exist. In the textile 
industry lacasses  have been used for indigo dye  bleaching  in denim  
 
 
 
 
 
 
 
 
 
finishing [10, 11] using commercial enzymes such as DeniLiteTM 
(Novozyme, Novo Nordisk, Denmark) and Zylite (Zytex Pvt. Ltd., 
Mumbai, India). A whole cell hydroxylation process of heteroarenes 
such as pyridine was developed by Lonza using Pseudomonas putida 
ATCC 33015 cells combining several oxidation steps by intrinsic 
mono- and dioxygenases [12-14]. This process was used for the 
production of 5-methylpyrazine-2-carboxylic acid, an intermediate for 
the production of an antilipolytic drug, by whole cell oxidation of 
2,5-dimethylpyrazine [13].  
Oxygenases hold a great potential for new applications in many 
fields, such as: textile, food, environment (biodegradation and 
bioremediation), biosensors, organic synthesis (chiral and asymmetric 
synthesis, polymers, pharmaceuticals), and biofuels [10, 15-18]. 
However, their potential is still far from being fulfilled. The practical 
use of oxygenases compared with other industrial enzymes such as 
hydrolases, lyases and isomerases, is limited by many factors [7, 8, 18, 
19]. Many oxygenases have poor stability in unnatural environments 
as most of them are membrane-associated multicomponent complexes. 
In addition, their function depends on reduction equivalents (e.g., 
NADH or NADPH) that need regeneration by electron transfer 
proteins [7, 18, 19]. The cofactor regeneration is one of the main 
limitations of industrial biooxidation processes as the oxidation of 
every substrate molecule requires one molecule of NAD(P)H. The 
supplementation of  the latter compounds in large amounts will make 
the production costs economically unfavorable [9]. Cofactor 
regeneration has been addressed by different approaches such as 
chemical, electrochemical, photochemical and enzymatic means. These 
possibilities were recently reviewed by Torres et al. [9]. A whole-cell 
system is an alternative solution to overcome some of these problems. 
However, in this case some disadvantages include generation of by-
products by enzymes present in the host, low oxygen mass transfer, 
toxicity of substrates and products, limited substrate uptake and 
insufficient  catalytic rate [18, 19]. In order to overcome the 
limitations discussed above, some modifications should be made to fit 
the process conditions to the available oxygenase properties 
(bioprocess engineering), or on the other hand the biocatalyst should 
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be improved to make it suitable for chemical manufacturing process 
conditions (e.g., pH, temperature, organic solvents and pressure) and 
demands (e.g., substrate specificity and range, high catalytic rate and 
production yields) [4, 6, 18]. 
The promising commercial potential of oxygenases, especially 
their high selectivity, provided a motivation for many protein 
engineering studies in the past two decades. Efforts were made to 
modify the structure and catalytic properties of oxygenases to suit 
industrial applications. In recent years, advances in molecular biology 
techniques, bioinformatics, computational methods and screening 
methods expanded the protein engineering “tool box” and opened 
new possibilities to design improved biocatalysts in terms of stability, 
catalytic activity, substrate scope and selectivity. This article reviews 
selected studies regarding non-heme oxygenases from recent years 
(2007-2012), which present diverse protein engineering approaches 
for targeting the desired biocatalyst property. A summary of these 
protein engineering reports is presented in Table 1.  
 
Protein engineering 
 
Protein engineering refers to the alteration of an existing protein 
structure in order to improve desired traits for targeted applications 
[20, 21]. It is generally composed of three major steps: 1) Choosing 
the template based on the desired application and the available 
enzyme; 2) Choosing the engineering strategy and mutagenesis 
approach. The decision depends on the data available (e.g. crystal 
structure, homology modeling, sequence alignment with homologues, 
and empirical results) and existing screening or selection methods. 
The mutagenesis strategies range between rational design (performed 
by site specific or saturation mutagenesis) to random directed 
evolution (performed by error prone PCR or family shuffling), and 
often the final strategy is a combination of the two; 3) Screening or 
selection for discovering those variants possessing the improved 
desired properties [20, 21]. The best variants of the mutagenesis cycle 
are isolated and characterized and in most cases serve as the template 
for further rounds of mutagenesis in order to improve the specific 
property or to add a different one (e.g., improve the catalytic rate and 
then improve the stability). A schematic diagram illustrating the 
protein engineering process is presented in Figure 1.  
The most popular and studied strategies in protein engineering are 
“rational design” and “directed evolution”. Both strategies have been 
used separately or in tandem to tailor enzymes for specific 
applications [1, 20, 21]. Rational protein design was originally based 
mostly on the available structural data for rationally choosing 
positions in the protein sequence for alteration to different amino 
acids. Nowadays, the data can be obtained not only from 3-D x-ray 
crystal structures, but also from homology modeling, docking models, 
sequence alignment of the protein and its homologues, previous 
experimental results, and statistical models available in the internet. 
The main limitation of the rational approach is that our 
understanding of the correlation between protein structure and 
function is limited, and the attempt to predict the influence of amino 
acid substitutions in specific positions may end in adverse results. As 
opposed to rational protein design, directed evolution of enzymes is 
based on the Darwinian principle of mutation and selection and not 
on a detailed understanding of enzyme structure and function [2, 22]. 
In this approach a diversity is generated by random mutagenesis (e.g., 
error prone PCR - epPCR) [23], or gene recombination (e.g., family 
shuffling) [24] for the creation of a mutant gene library which covers 
a large sequence space. The library is screened for the desired property 
and the improved variants are isolated for the next round of 
mutagenesis and screening. The main drawback of this approach is the 
need for a high throughput screening or selection method which may 
not be available.  The screening problem is emphasized when the 
desired property is regio- or enantioselectiviy as in many cases those 
reactions products can be analyzed mainly by low throughput 
screening methods (e.g., GC, HPLC) [25].  
 
 
 
 
 
 
 
 
 
 
 
 
 
In recent years, the main approach in protein engineering studies 
is data-driven protein design. This tactic combines both strategies in 
order to create relatively small size “smarter” libraries (102-104) by 
utilizing structural knowledge (crystal structure, homology models, 
empirical results) and statistical methods to predict beneficial 
alterations for the desired trait (e.g., thermostability, selectivity) [6, 
20]. This approach is supported by the increasing amount of data in 
databases (more than 75,000 protein structures are available in the 
protein data bank), next-generation DNA sequencing, bioinformatics, 
and computational tools. Creation of smaller libraries reduces the 
screening efforts and enables screening assays closer to the industrial 
application conditions. For example, a protein engineering approach 
such as iterative saturation mutagenesis (ISM) [26], combines 
selection of few positions in the enzyme which may influence the 
desired property using structural data, and evolutionary 
randomization by stepwise applying  saturation mutagenesis at every 
position. The best variant of every library is used as the template for 
saturation mutagenesis at a different position [25, 26].  This 
approach was combined with saturation mutagenesis using reduced 
amino acid alphabets such as NNK codon degeneracy (32 codons/20 
aa) or NDT (12 codons/12 aa) codon degeneracy ( N represents A, 
T, G or C,  and  K represents G or T, D represents A, G or T) for the  
Figure 1. A schematic diagram illustrating the protein engineering process. 
1. Choosing the gene template encoding for the desired enzyme and 
cloning into a suitable host. 2. Choosing the engineering strategy and 
mutagenesis methods that will give the best results in the shortest time 
using the minimum effort. 3. Screening or selection for variants possessing 
the desired property. The best variants can be used as the template for 
further rounds of mutagenesis and screening for the same property or a 
different one. The protein engineering process continues until the 
biocatalyst with the desired properties is obtained. 
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a new enzyme represented by the amino acid substitution (in a single letter code), slashes indicate that all substitutions are in the same enzyme. Abbreviations: 
StyMO - styrene monooxygenase, T4MO - toluene-4-monooxygenase, Tyr- tyrosol, PEA – 2-phenylethanol, BPDO - biphenyl dioxygenase, HTyr – hydroxytyrosol, 
sMMO - soluble methane monooxygenase, PAMO - phenylacetone monooxygenase, AtdA - aniline dioxygenase, IsoB - catechol 1,2-dioxygenase, C23O - 
catechol-2,3-dioxygenase, AkbA - o-xylene dioxygenase, NBDO - nitrobenzene dioxygenase, LadA  - alkane monooxygenase.  
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creation of relatively smaller libraries with high functionality [25]. 
Many other tools and techniques for the generation of industrial 
biocatalysts are available and reviewed by Bommarius et al. [20] and 
by Bornscheuer et al. [27]. A good protein engineering process is the 
one that will give the desired results in the shortest period of time 
with a reasonable effort. However, the choice of a good protein 
engineering strategy depends on one’s “tools box”, information 
intensity (crystal structure, previous studies and experimental results), 
mutagenesis methods, and screening/selection techniques [21].  
 
Engineering non-heme oxygenases 
 
Selective hydroxylation of aromatic compounds is of great interest 
to organic chemists. Members of the toluene monoxygenase (TMOs) 
family were extensively investigated for their ability to perform highly 
regio- and enantio-selective hydroxylation of such compounds [28-
31]. TMOs belong to a group of four component, non-heme, diiron 
alkene/aromatic monooxygenases [32]. Their hydroxylase is 
composed of two subunits in (αβγ)2 quaternary structure and the 
electron transfer from the NADH reductase to the hydroxylase is 
mediated by a Rieske-type [2Fe-2S] ferredoxin [32]. In recent years 
members of this monooxygenase family were the focus of protein 
engineering studies aiming to improve their catalytic ability in terms 
of rate, substrate scope and selectivity.  
Toluene 4-monooxygenase (T4MO) of Pseudomonas mendocina 
KR1 and toluene ortho-monooxygenase (TOM) of Burkholderia 
cepacia G4 were investigated for their ability to perform 
enantioselective oxidation reactions of aromatic sulfides [33]. Position 
V106 in the α-hydroxylase subunit of TOM and the analogous 
position, I100 of T4MO, were chosen for mutagenesis based on 
previous work by Wood and co-workers in which this residue was 
found to influence the enzyme regiospecificity in hydroxylation 
reactions [34, 35]. Saturation mutagenesis libraries, expressed in E. 
coli and tested in whole-cell systems, were screened for improved 
activity and enantioselectivity on methyl phenyl sulfide and methyl 
para-tolyl sulfide using gas chromatography (GC) (Figure 2b). TOM 
variant V106M showed an improved oxidation rate of 3.0 
nmol/min/mg protein for methyl phenyl sulfide to the 
corresponding sulfoxide compared with 1.6 for the wild-type enzyme, 
together with an increased enantiomeric excess of 88% (pro-S) vs. 
51% for the wild type. T4MO variant I100G showed an increased 
oxidation rate by 1.7-fold with an improved enantiomeric excess of 
98% (pro-S). In addition, I100G oxidized methyl para-tolyl sulfide at 
a higher rate of 11-fold compared to the wild type and changed the 
selectivity from 41% pro-R to 77% pro-S [33].  
These results highlighted the importance of residues V106 
(TOM) and its analogue I100 (T4MO) for tuning activity and 
selectivity of unnatural substrates. It was hypothesized that TOM 
V106 possess an important role in the proper positioning of the 
substrate with respect to the diiron atoms. Based on the experimental 
results it was suggested that a decreased oxidation rate and impaired 
enantioselectivity were a result of a substrate not properly aligned in 
the active site [33].  
Further investigation was done by Brouk et al. in order to have a 
better understanding on the influence of residues in the tunnel leading 
to the active site vs. active site residues of T4MO [36]. The chosen 
positions for saturation mutagenesis were residue D285 which is 
located at the tunnel entrance distant from the active site, and residue 
I100 located in the active site close to the diiron center (Figure 3A) 
[33]. Using three different substrates, the libraries were screened for 
their activity, regioselective hydroxylation of 2-phenylethanol (PEA) 
and enantioselective oxidation of styrene and of methyl p-tolyl sulfide 
(Figure 2a-b). This study revealed that mutations at position 285 at 
the tunnel entrance improved the oxidation rate without affecting the 
regio- and enantioselectivity. The best amino acid substitution for 
enhanced activity was found to be substrate dependent. D285I and 
D285Q enhanced the oxidation rate of PEA and methyl p-tolyl 
sulfide (large and bulky substrates) by 8–11-fold compared to wild 
type, while variant D285S improved the oxidation rate of styrene to 
styrene oxide by 1.7-fold. The activity and selectivity of T4MO 
towards all three substrates was influenced by substitutions at position 
I100. An additive or even synergistic effect on the enzyme activity and 
selectivity was further achieved when site directed mutagenesis was 
applied to combine the best substitutions of both positions. 
I100A/D285Q and I100A/D285I enhanced the oxidation rate of 
PEA by 85- and 52-fold respectively, with improved regiospeceficity 
towards m-tyrosol (91-93%, respectively) [36]. 
 Based on the results it was concluded that residue 285 which is 
located in the entrance to the tunnel leading to the active site 
influences the substrate/product flow to/from the active site without 
changing the regio- and enantioselectivity. In contrast, residue 100 
which is part of the hydrophobic gate in the active site entrance 
affected both activity and selectivity, by improving flux into the diiron 
center and by changing the size of the active site pocket [36, 37].   
Toluene o-xylene monooxygenase (ToMO) from Pseudomonas 
sp. strain OX1was also investigated for the ability to hydroxylate PEA 
to tyrosol (Figure 2a). Notomista et al. [38] used a computational 
strategy based on Monte Carlo approach to predict the effect of 
amino acid substitutions in the active site of the ToMO hydroxylase 
subunit on the enzyme’s regioselectivity on aromatic substrates [39]. 
A kinetic model of the active site with productive and unproductive 
enzyme-substrate complexes was built in order to locate residues and 
possible substitutions that will improve the hydroxylation activity of 
ToMO on PEA and tune the regioselectivity from m-tyrosol (90% in 
the wild type) to p- tyrosol. Based on the model, positions E103 and 
F176 were predicted to influence the regioselectivity and catalytic 
efficiency of the reaction as both of them contribute to the active site 
cavity edge (Figure 3B). Site directed mutagenesis was used to create 
variant E103G and three different variants of F176 (I, L, T) and six 
double mutants of E103G/F176 (I, L, T, A, S, V). All F176 variants 
hydroxylated PEA exclusively to p-tyrosol. E103G showed similar 
regioselectivity as wild type, but the double mutated variants showed 
improved catalytic efficiency and regioselectivity (Table 1) [38].   
TMOs were engineered to perform successive double 
hydroxylation of PEA to form hydroxytyrosol (HTyr), a valuable 
natural phenolic compound with exceptional antioxidant, 
antimicrobial and anticarcinogenic activities (Figure 2a) [37]. 
Saturation mutagenesis libraries of TOM V106 and T4MO I100 
and a random mutagenesis library of T4MO at the α- and γ-
hydroxylase subunits, generated by epPCR, were screened on PEA, o-, 
m- and p-tyrosol. The screening method was based on the instability 
of the catechol derivatives which auto-oxidize and polymerize forming 
red-orange dye [40]. Colonies showing a red halo were chosen for 
whole cell biotransformation analysis with product measurement 
performed with GC/MS. Both targeted and random libraries 
generated mutants with improved oxidation activity compare to wild 
type. However, T4MO mutants I100A, I100S and I100G and TOM 
mutants V106S, V106A and V106E performed the di-hydroxylation 
of PEA to form the desirable HTyr.  In addition, T4MO S395C 
variant from the random mutagenesis library showed a 15-fold 
improved activity on PEA and hydroxylated o-tyrosol to form 2,3-
dihydroxyphenyl ethanol, a reaction not performed by wild-type. 
Position 395 is distant from the active site but was found to influence 
both  the  activity  and  selectivity of the enzyme [37]. These results  
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emphasize the strength of classical directed evolution methods in 
targeting important positions influencing the enzyme activity which 
are not expected to be found by rational design methods. 
Further improvement of T4MO hydroxylation activity on PEA to 
form HTyr was achieved by integrating statistical modeling into 
protein engineering [41]. The statistical model of Nov and Wein 
[42], which addresses the protein design problem by capturing 
characteristics of protein structure-activity relationship, was used to 
predict 16 beneficial mutant combinations (out of ~13,000 
possibilities) in two rounds of statistical analysis. Seven double or 
triple mutants were suggested based on an initial data set from 
previous studies [36, 37].  These mutants showed a 4.6-fold 
improvement in the average activity compare to the average activity of 
the initial data set variants. A second round of statistical analysis 
generated nine mutants with 3-5 point mutations. The second round 
mutants had 7.3-fold improvement in the average activity compared 
to the initial data set. T4MO variant I100A/E214G/D285Q was 
the best enzyme with an initial PEA oxidation rate of 4.4 ± 0.3 
nmol/min/mg protein which is190-fold higher than wild type and 
also 2.6-fold higher than the wild type activity on toluene, the natural 
Figure 2. Selected non heme mono- and dioxygenase reactions: a. PEA hydroxylation by toluene monooxygenases (TMOs) to p- and m-tyrosol and successive 
hydroxylation to form hydroxytyrosol (HTyr) [36-38, 41]. b. Methyl-p-tolyl sulfide oxidation by T4MO to (S)-, (R)-methyl-p-tolyl sulfoxide [33, 36]. c. Styrene 
epoxidation by StyMO to (S)-styrene oxide [45]. d. 2-Phenylcyclohexanone oxidation by phenyl acetone monooxygenase (PAMO) [48]. e. Biphenyl 
hydroxylation to 2,3-dihydroxybiphenyl by BPDO (BphA – biphenyl dioxygenase, BphB – dihydrodiol dehydrogenase) [49, 50]. 
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substrate [41]. This study demonstrated that the combination of 
statistical modeling with rational design and directed evolution, may 
lead to a highly active biocatalyst in minimum time and screening 
efforts. 
New crystal structures of the T4MO hydroxylase subunit 
(T4moH ) bound to 4-bromophenol, and the complex of T4moH 
with the  effector protein T4moHD bound to the natural product p-
cresol have been reported  recently by Bailey and coworkers [43]. 
These structures can be used for further engineering of T4MO to 
enhance its activity in desired reactions.  
Another enzyme which was extensively studied is styrene 
monooxygenase (StyMO). StyMO is a flavoenzyme consisting of two 
components, StyA – an FAD dependent monoxygenase, and StyB – 
an NADH reductase. StyMO catalyzes predominantly the (S)-
epoxidation of m- and p-styrene derivatives to form the 
corresponding styrene oxides (Figure 2c) [4, 44]. Pseudomonas 
putida CA-3 StyMO genes, StyAB, were subjected to three rounds of 
random mutagenesis by epPCR in order to improve the rate 
formation of styrene oxide and indene oxide [45]. The screening 
method was based on a colorimetric method of indole 
biotransformation to indigo. The best clones were isolated and used 
for the biotransformation of the styrene and indene to the 
corresponding oxides. Although the screening method was based on a 
different substrate than the target, 9-12-fold improvement was 
obtained for styrene and indene oxidation while the enantioselectivity 
remained high (Table 1). Most of the mutations of the improved 
variants were located in StyA together with an insertion mutation that 
changed the translation reading frame and added 19 amino acids to 
the StyA subunit [45]. 
Rational design was used to improve the activity of StyMO from 
Pseudomonas sp. LQ26 towards α-ethylstyrene [46]. Four mutants 
(R43A, L44A, L45A, and N46A) were designed based on a docking 
model [47] using the x-ray crystal structure of the StyMO epoxidase 
subunit from P. putida S12 (PDB code 3IHM). All variants displayed 
different substrate preference. The most active variant was L45A with 
3-fold improved activity on α-ethylstyrene [46]. 
 
Baeyer-Villiger monooxygenases 
 
Baeyer-Villiger monooxygenases (BVMO) are flavin-dependent 
monooxygenases which catalyze the Baeyer-Villiger oxidation of 
ketones to form lactones or esters. The use of BVMO to catalyze 
these reactions enantioselectively is an attractive alternative to the 
traditional metalo- organo-catalysts used by organic chemistry [51, 
52].  
Phenyl acetone monooxygenase (PAMO) from Thermobifida 
fusca, the only known thermostable BVMO [53], was the subject of 
protein engineering studies conducted by the Reetz group [48, 51, 
54]. Three different strategies were used to expand the narrow 
substrate range of PAMO. Positions 441-444 on a loop having a 
direct contact with the binding pocket were chosen for mutagenesis 
based on previous studies [55] and on sequence alignment with seven 
other BVMOs (Figure 3C). A degenerate codon was used to 
introduce all possible amino acids occurring in a specific position 
according to the sequence alignment [54]. Only 1700 clones were 
screened for the oxidative resolution of 2-phenylcyclohexanone 
(Figure 2d) in a whole-cell system with 145 variants exhibiting 
improved activity compare to the wild type. Some of the best variants 
were isolated and tested for their activity and thermostability. These 
variants displayed different enantioselectivity (pro-S or pro-R) and 
had high thermostability as the WT did. The highest 
enantioselectivity (E-Value = 70, pro-R) was displayed by variant 
S441A/A442W/L443Y/S444T [54]. According to the PAMO x-
ray structure, residues 441–444 are located near R337 of the active 
site (Figure 3C) which has been suggested to stabilize the Criegee 
intermediate [54]. The results confirmed that mutagenesis of these 
residues can influence the substrate acceptance and enantioselectivity 
[54].This study also demonstrates the successful use of degenerate 
codon alphabet in several targeted positions, for reducing the 
screening efforts while achieving great improvement in catalytic 
activity.   
Bioinformatics was used to further improve these results. Position 
440 was chosen for mutagenesis based on a docking model of the 
ligand phenylacetone in wild type PAMO (PDB code 1W4X) 
(Figure 3C) [51]. A library was generated by saturation mutagenesis 
using NNK codon degeneracy and screened for the ability to perform 
oxidative kinetic resolution of 2-ethylcyclohexanone. The activity test 
was done with isolated enzymes in conjunction with  an alcohol 
dehydrogenase from Thermoanaerobacter ethanolicus for NADPH 
regeneration using isopropanol as the reductant [51]. Seven variants 
with improved activity were found (Table 1). The best variants were 
further evaluated on other 2-substituted cyclohexanone substrates. All 
variants attained an expanded substrate scope of 2-substituted 
cyclohexanones and high enantioselectivity while maintaining their 
thermostability. The most active variant, P440F, had 160-fold 
improved rate for the kinetic resolution of 2-phenylcyclohexanone 
compare to the wild type [51].  P440 is located on a flexible loop in 
the second shell surrounding the active site (Figure 3C). Mutagenesis 
of a proline residue most likely changed the loop configuration which 
resulted in changes in substrate acceptance, enantioselectivity, and 
oxidation rate [51].  
A different approach to influence the catalytic activity and 
increase the substrate range of PAMO, was the use of mutagenesis in 
a distant region from the active site with the aim to trigger 
allosterically-induced domain movements and to create a new binding 
pocket [48]. Based on the PAMO crystal structure, positions 
Q93/P94 which are located in the N-terminal region of an α-helix 
were chosen for mutagenesis (Figure 3C). Saturation mutagenesis 
using the NDT codon degeneracy was performed simultaneously on 
both positions and activity was measured in a cell free system on the 
model reaction of oxidative kinetic resolution of 2-
ethylcyclohexanone [51]. Q93N/P94N was the most active variant 
found from screening 400 transformants.  Its activity was further 
tested on 2-substituted cyclohexanones demonstrating vast substrate 
acceptance by the mutant with high enantioselectivity. However, when 
mutagenesis was performed separately at each position, no active 
enzymes were found [51]. 
 
Soluble methane monooxygenases 
 
Soluble methane monooxygenase (sMMO) is a catalytically 
versatile enzyme that can catalyze the oxygenation of unreactive 
methane to methanol, as well as a wide range of other substrates such 
as, naphthalene, biphenyl, carbon monoxide and ammonia [60, 68]. 
sMMO is a multicomponent enzyme comprising of an (αβγ)2 
hydroxylase component, an NAD(P)H-dependent reductase with an 
FAD and an Fe2S2 center, and an effector protein, all encoded by a 
multigene operon mmoXYBZDC [60, 68]. Its catalytic abilities 
present great potential for the development of a robust biocatalyst for 
synthetic chemistry and bioremediation [60, 68]. However, the main 
obstacle concerning protein engineering of sMMO is the difficulty to 
achieve functional expression of this multicomponent enzyme in E. 
coli [68]. A partial solution addressing this problem was developed by 
Smith and coworkers, in which  mutagenesis  was  performed  on  the  
Non-Heme Mono- and Dioxygenases 
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relevant gene in a specially designed vector in E. coli cells. The mutant 
gene was then transferred using a shuttle plasmid by conjugation to 
Methylosinus trichosporium with a partially deleted mmoXYBZDC 
operon [60, 68, 69]. This expression system was used for site directed 
mutagenesis of sMMO from M. trichosporium strain OB3b at 
position L110 (Figure 3D) [60]. Based on the hydroxylase crystal 
structure and on comparison to homologues, L110 located in the 
entrance to the active site was suspected to influence the substrate 
acceptance for large aromatic molecules and the regioselectivity of the 
enzyme [60]. Indeed, all mutants (L110G, L110C, L110R and 
L110Y) showed a change in their regioselectivity compare to the wild 
type (Table 1). Variants L110R and L110Y had an inverted 
regioselectivity in naphthalene hydroxylation (1-naphtol, 70.6 and 
74.8% respectively). Novel products were generated by all variants in 
the hydroxylation of toluene (m-cresol) and ethyl benzene (2-
ethylphenol) with moderate regioselectivity, and L110G and L110C 
hydroxylated biphenyl to 3-hydroxybiphenyl. However, the mutants 
were not able to hydroxylate larger aromatic hydrocarbons such as 
anthracene and phenanthrene [60]. Based on the research results it was 
suggested that residue 110 has a crucial role in coordinating the 
substrate in the active site pocket and controlling the precision of 
regioselectivity, rather than limiting the size acceptance of substrates 
to the active site [60]. These results underscore the great potential of 
this monooxygenase as a biocatalyst; nevertheless, a suitable expression 
system still limits the practical applications.   
Dioxygenases 
 
Dioxygenases are non-heme Rieske type NADPH-dependent 
enzymes which catalyze the introduction of two oxygen atoms into an 
organic substrate. This heterogeneous group has an important role in 
the natural biodegradation and industrial bioremediation of aromatic 
compounds, such as polychlorinated biphenyls (PCBs), naphthalane 
and polycyclic arenes [7, 8, 70]. Dioxygenases are also 
multicomponent enzyme complexes composed of an oxygenase 
subunit, an iron-sulfur flavo-protein reductase, and a ferredoxin [7]. 
In recent years, protein engineering has been used to improve the 
catalytic rate, regioselectivity and thermostability of dioxygenases for 
biosynthesis and bioremediation purposes.  
Biphenyl dioxygenase (BPDO) catalyzes the first step in biphenyl 
biodegradation (Figure 2e). The regiospecificity of BPDO from 
Burkholderia xenovorans LB400 was successfully changed to accept 
2,2’-dichlorobiphenyl by the use of family shuffling of bphA genes 
from polychlorinated biphenyl-contaminated soil DNA combined 
with site specific mutagenesis [50]. BPDO oxidation of the refractory 
flavonoids, 7-hydroxyflavone and 5,7-dihydroxyflavone (Chrysin) to 
their vicinal diol forms was enhanced by constructing a hybrid of the 
dioxygenase large α subunit , BphA1, followed by saturation 
mutagenesis using NNK codon at positions 324 and 325 of bphA1. 
The hybrid was composed of amino acid sequence between positions 
268–397 of BphA1 from P. pseudoalcaligenes strain KF707 which 
Figure 3. A. The tunnel and active site region of the α-subunit of T4MO hydroxylase (PDB code: 3DHG [56]). Key residues which were subjected to mutagenesis 
in the tunnel entrance (D285) and in the active site (I100) are marked in cyan. The Fe atoms are colored as brown spheres. The helix segment between residues 
I61-Y82 was truncated to enable the visualization of the tunnel and the active site. B. The active site of the α-subunit of ToMO hydroxylase (PDB code: 1T0Q 
[57]). Key residues which were subjected to mutagenesis are colored by cyan (E103 and F176). The Fe atoms are colored as brown spheres. The helix segment 
between residues E486-Q491 was truncated to enable the visualization of the active site pocket. C. The active site region of PAMO with bound FAD (green) and 
NADP+ (dark pink) (PDB code: 2YLR [58]). Key residues which were subjected to mutagenesis are colored by cyan (P440, S441, A442, L443, S444, Q93 and P94). 
Active site residue R337 is colored by light pink. D. The active site region of the sMMO hydroxylase (PDB code: 1XU3 [59]). Residue L110 which was subjected to 
mutagenesis is colored by cyan. The Fe atoms are colored as brown spheres. All structures were visualized using PyMOL. 
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was exchanged with the corresponding sequence of P. putida strain 
KF715. The hybrid bphA1 was cloned together with bphA2A3A4BC 
genes from strain KF707 in E. coli JM109 for expression and whole 
cell biotransformation [49]. 
Site directed mutagenesis based on previous studies [71] and 
molecular modeling of o-xylene dioxygenase (AkbA) from 
Rhodococcus sp. strain DK17 was used to improve its hydroxylation 
ability of biphenyl. Variant L266F had an elevated hydroxylation 
activity on biphenyl to produce 2-hydroxybiphenyl (2.43 vs. 0.1 
mg/L) and 3-hydroxybiphenyl (1.97 vs. 0.03 mg/L) compare to 
wild-type [65].  
Site-specific saturation mutagenesis based on homology modeling 
was used to extend the substrate range of aniline dioxygenase (AtdA) 
from Acinetobacter sp. strain YAA [61]. The best variant, V205A, 
was used as the template for another round of saturation mutagenesis 
in the active site residue I248 followed by one round of random 
mutagenesis to enhance the bioremediation activity of aromatic 
amines. Triple mutant V205A/I248L/S404C showed the most 
significant improvement as its activity was increased by 3.5-fold over 
the wild type on the carcinogenic aromatic amine, 2,4-dimethylaniline 
[62]. 
Nitrobenzene dioxygenase (NBDO) form Comamonas sp. strain 
JS765 was evaluated for the ability to perform enantioselective 
oxidation of aromatic sulfides to the corresponding sulfoxides. By 
examining different para-substituted alkyl aryl substrates, NBDO 
oxidation activity was found to be dependent on the substrate size 
[66]. In order to improve the oxidation activity and enhance the 
enantioselectivity, five positions, V207, F222, N258, F293 and 
N295, were chosen for saturation mutagenesis based on previous 
work [72, 73], alignment with homologue aniline dioxygenase [62] 
and the HotSpot Wizard [74]. HotSpot Wizard is a web server 
designed for the identification of residues favorable for mutagenesis in 
the enzyme structure (“hot spots”) [74]. The libraries were tested in a 
whole-cell biotransformation for the oxidation activity and 
enantioselectivity of four substrates, thioanisole, p-tolyl sulfide, 
chloro-thioanisole and bromo-thioanisole. Variant N258A which 
showed improved enantioselectivity (pro-R) and increased activity 
towards all substrates and variant F293H which showed enhanced 
activity and moderate enantioselectivity, were combined by site 
specific directed mutagenesis. The double mutant, N258A/F293H 
had improved enantioselectivity as variant N258A and improved 
activity towards all four substrates, especially towards thioanisole 
(26.7-fold improved oxidation) (Table 1) [66]. Variants V207I and 
V207A had decreased activity but with opposite enantioselectivity; 
V207I had improved pro-R enantioselectivity and V207A had the 
reversed pro-S enantioselectivity (Table 1) [66]. A substrate docking 
model was generated using AutoDock Vina [75] in order to obtain 
better understanding of the correlations between the substrate 
structure and the enzyme activity. Based on the model, it was 
suggested that the enantioselectivity and activity of NBDO is 
determined by the substrate positioning in the active site which is 
coordinated by hydrophobic interactions and steric considerations 
[66].  
Catechols and chlorinated catechols are considered as carcinogenic 
and teratogenic pollutants which therefore must be removed from the 
environment [63]. Catechol dioxygenases and chlorocatechol 
dioxygenases play an important role in the detoxification of these 
pollutants. Site specific mutagenesis and site specific saturation 
mutagenesis based on homology modeling and sequence alignment 
were applied on catechol 1,2-dioxygenase (IsoB) from A. 
radioresistens S13 to fine-tune the catalytic properties and improve 
the activity on bulky catechol derivatives [63]. Variants at position 
L69 had inverted specificity favoring 4-chlorocatechol and enhanced 
activity on other chlorinated catechols while variants at position A72 
enhanced the activity rate on chlorinated catechols [63]. 
Stability under industrial conditions is a major issue for the 
application of biocatalysts in a production process. Thus, the 
thermostability of catechol-2,3-dioxygenase (C23O) from 
Pseudomonas sp. CGMCC2953 was improved by introducing 
disulfide bonds [64]. Potential sites for forming disulfide bonds were 
analyzed using Modip, a web-based disulfide bond prediction server 
[76] and the chosen mutations were introduced by site specific 
mutagenesis. By introducing cysteine residues at positions A229 and 
H294 a disulfide bond was created. The mutagenesis outcome was 
indeed improved thermostability and enhanced alkali stability [64]. 
 
Conclusions  
 
Non-heme oxygenases are attractive biocatalysts for organic 
chemistry due to their high chemo-, regio-, and enantioselectivity. 
Protein engineering was applied to these enzymes mainly to enhance 
the catalytic rate, expand the substrate range for unnatural substrates 
and fine tune the selectivity. Properties affecting enzyme stability 
under reaction conditions, such as thermostability, were generally not 
studied. Many of the studies reviewed, used a data-driven protein 
engineering approach to successfully evolve new enzymes with 
improved catalytic properties. However, the classic strategy of 
directed evolution by random mutagenesis was proven to be an 
important tool as well, as it helped in locating positions distant from 
the active site affecting the enzyme catalytic activity, which are less 
likely to be found in a more rational approach.  
An appropriate engineering strategy is one that allows reaching the 
target in the shortest time with minimum screening efforts. Directed 
evolution generated by random mutagenesis covers a large sequence 
space however requires high throughput screening of large libraries. 
For example, directed evolution by epPCR was used to enhance 
T4MO hydroxylation activity. By screening more than 3000 clones 
one mutant with 15-fold improved activity and altered selectivity was 
found [37]. Similarly, epPCR was applied to enhance the hexadecane 
hydroxylation activity of LadA. By screening 7,500 clones of a 
random mutagenesis library, 3 mutants with 2-fold improved activity 
were found. The improved variants were further subjected to site 
specific saturation mutagenesis which resulted in a mutant performing 
3.4-fold better than the wild type [67]. The data-driven approach on 
the other hand, focuses on the mutagenesis of targeted positions with 
high potential to influence the desired property along with the use of 
restricted codon degeneracy for the creation of relatively small 
libraries. This strategy was successfully used to improve PAMO 
activity by generating two site specific saturation mutagenesis libraries 
of 200 clones each. The best mutant of this study, exhibited 160-fold 
improvement in rate for the kinetic resolution of 2-
phenylcyclohexanone [51]. This strategy was also applied to improve 
the activity of T4MO hydroxylation of phenylethanol to 
hydroxytyrosol. By generating two site specific saturation mutagenesis 
libraries of 300 clones each, and combining the best mutations of 
each library, an 85-fold improvement was achieved [36, 37]. Further 
improvement was obtained by using statistical model predictions for 
the best mutation combination. By generating only 16 variants out of 
~13,000 possibilities, a triple variant with 190-fold improved activity 
was obtained [41]. In both studies successful results were obtained 
while minimizing the screening efforts to only few hundreds compare 
to the large libraries which are inherent in directed evolution 
protocols (103-106) [1, 2].  With the ever-increasing generation of 
new data on enzymes, whether by new crystal structures or sequences, 
or through reports by numerous laboratories involved in enzyme 
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engineering, we believe that the data-driven approach will become 
more popular and widespread. 
Another observation from the studies reviewed, was that most of 
the researchers employed whole cell systems for the biotransformation 
to circumvent the need for co-factor regeneration. The issue of 
NAD(P)H regeneration still requires perfection in order to fulfill the 
maximum potential of oxygenases as industrial biocatalysts.  
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